 |
Anthony H. Wild, PhD
Chairman and CEO
Anthony H. Wild, Ph.D., is Chairman and CEO of MedPointe. He brings a wealth of experience gained in a global career of 30 years in the pharmaceutical industry.
|
Prior to joining MedPointe, Tony served as Executive Vice President of Warner-Lambert and President of its Pharmaceutical Sector (until the merger with Pfizer in June 2000), with worldwide responsibility for Warner-Lambert’s pharmaceutical commercial operations and research and development. Under his leadership, Warner-Lambert’s pharmaceutical business grew from $2.1 billion in sales with 14,000 employees in 1995 to an estimated $9.5 billion in 2000 with 21,000 employees and a $1.3 billion R&D budget. During this period, Tony oversaw a number of acquisitions including those of Jouveinal (France), Hickson (Eire) and Agouron (La Jolla), the setting up of the US joint-venture with Sankyo and that of the Pfizer global LIPITOR partnership.
Prior to joining Warner-Lambert in 1995 (initially as President of Parke-Davis North America before assuming global responsibilities in 1996), Tony spent 22 years with Schering-Plough Corporation in Switzerland, Sweden, South Africa, the Netherlands, United States, and culminating as President of Schering-Plough’s Japanese operations, a $500 million business, including a complex web of licensee/ licensor partnerships with major Japanese companies. Prior to that, he was employed at Sandoz AG in Basel, Switzerland, as a Development Chemist, where he worked on optimization and simulation of chemical processes.
Dr. Wild is a member of the Board of Advisors to the Joseph L. Mailman School of Public Health at Columbia University, a Trustee of the Healthcare Institute of New Jersey, past Chairman of the International Section of Pharmaceutical Research and Manufacturers of America, and past Governor of the American Chamber of Commerce in Japan.
Dr. Wild graduated from the University of York with a B.A. honors degree in Chemistry and received a Ph.D. in Physical Chemistry from the University of Cambridge (Churchill College), both in the U.K.
Meda Pharmaceuticals